HIKALNSEHIKAL LIMITED· Pharmaceuticals & BiotechnologyCriticalNegative
Announced Thu, 1 Oct, 2026 · 15:21 IST

Hikal: Founder ends Chairman term, director resigns, new divisional CEO appointed

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.4%Reaction day
₹217.68
prior close
₹218.52
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+1.7% vs market
Pharmaceuticals peers, median of 173sector-0.8%+1.2% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.4-1.3+1.7-0.8+1.2
Next day
-1.2-1.3+0.1-1.3+0.0
2d
+3.9+0.0+3.9-0.4+4.3
3d
+3.8-0.2+4.0-0.1+4.0
4d
-2.4-3.0+0.6-3.1+0.7
5d
-2.0-2.7+0.7-3.1+1.1
1w
-1.8-1.7-0.1-3.1+1.3
15d
-11.2-8.9-2.3-6.9-4.3
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Jai Hiremath, founder, ended his term as Executive Chairman on Oct 1, 2026 after nearly four decades. He takes an honorary Chairman Emeritus role for five years but is no longer a Director or KMP. Non-Executive Director Mrs. Sugandha Hiremath (on board since 1992) resigned effective Sept 30, 2026 for personal reasons, also exiting Audit, Stakeholders' Relationship and CSR Committees. Mr. Anish Swadi, internal since 2021, appointed CEO of Animal Health and Specialty Ingredients.

Likely market impact

Significant leadership change at Hikal. Founder exits executive role, family director resigns, new divisional CEO appointed. Watch succession closely.